Correction to “The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSleep and Wakefulness Research · Sleep and related disorders
Campbell EJ, Bonomo Y, Collins L, et al. The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report. Clin Case Rep. 2024; 12:e8740. doi:10.1002/ccr3.8740
In the article entitled “The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report” that was previously published in Volume 12 Issue 5 of Clinical Case Reports, the address in the correspondence section for Andrew J. Lawrence has been corrected.
The correct address for Andrew J. Lawrence in the correspondence section should be: Andrew J. Lawrence, The Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, The University of Melbourne, Parkville, Vic 3052, Australia.
We apologize for this error.